FDA Approves FINASTERIDE — Sun Pharmaceutical Industries, Inc.

# FDA Approves Sun Pharmaceutical's Generic Finasteride Sun Pharmaceutical Industries, Inc. received FDA approval for its generic finasteride formulation on July 1, 2013, marking another entry into the competitive male pattern baldness and benign prostatic hyperplasia treatment market. The approval is expected to increase price competition in the oral finasteride segment and expand patient access to the widely-used therapeutic agent.